FDA approves powerful new opioid

Despite the ongoing opioid crisis plaguing the nation, the US Food and Drug Administration on Friday approved a new opioid medication five to 10 times more powerful than fentanyl.

Posted: Nov 4, 2018 9:31 AM

(CNN) -- Despite the ongoing opioid crisis plaguing the nation, the US Food and Drug Administration on Friday approved a new opioid medication five to 10 times more powerful than fentanyl.

Dsuvia, made by AcelRx Pharmaceuticals Inc., is a tablet in a single-dose, prefilled applicator to be administered under the tongue by health care providers to patients in settings such as hospitals, surgical centers and emergency rooms, according to the company.

FDA Commissioner Dr. Scott Gottlieb was quick to defended the approval in a statement Friday: "The agency is taking new steps to more actively confront this crisis, while also paying careful attention to the needs of patients and physicians managing pain."

In April, Gottlieb told CNN Chief Medical Correspondent Dr. Sanjay Gupta that opioids are the biggest crisis facing the nation, a crisis fueled by overprescribing. The numbers say it all: More people die in the US each year from drug overdoses than from breast cancer.

Following the approval of Dsuvia, Gottlieb acknowledged that opioids are a unique class of medications. "I recognize that the debate goes beyond the characteristics of this particular product or the actions that we're taking to mitigate this drug's risks and preserve its differentiated benefits. We won't sidestep what I believe is the real underlying source of discontent among the critics of this approval -- the question of whether or not America needs another powerful opioid while in the throes of a massive crisis of addiction," he said.

But the criticism was quick. "The U.S. Food and Drug Administration (FDA) is recklessly and needlessly endangering people by approving a super-strong opioid," a statement from the public advocacy group Public Citizen said in response to the approval. The group noted that Dsuvia is five to 10 times more powerful than fentanyl and 1,000 times more potent than morphine.

"It is certain that Dsuvia will worsen the opioid epidemic and kill people needlessly," said Dr. Sidney Wolfe, founder and senior adviser of Public Citizen's Health Research Group.

"DSUVIA will not be available in retail pharmacies or for outpatient use. DSUVIA will only be distributed to health care settings certified in the DSUVIA Risk Evaluation and Mitigation Strategy (REMS) program following attestation by an authorized representative that the healthcare setting will comply with appropriate dispensing and use restrictions of DSUVIA," AcelRx said.

Other restrictions, according to the FDA, include that it cannot be used for more than 72 hours and will have the same black-box warnings as are required for all opioids about the risk of misuse and abuse that can lead to addiction and overdose death.

"Because of the risks of addiction, abuse and misuse with opioids; Dsuvia is also to be reserved for use in patients for whom alternative pain treatment options have not been tolerated, or are not expected to be tolerated, where existing treatment options have not provided adequate analgesia, or where these alternatives are not expected to provide adequate analgesia," according to a statement from Gottlieb about the drug's approval.

The statement noted the benefit the drug could have for soldiers injured on the battlefield. It notes that the Department of Defense was involved in its development and that it was a priority for the Pentagon because it "fills an unmet need."

The same drug, with the chemical name sufentanil, is already available as an IV medication. In its newly approved form, it is an option for patients with acute pain who are not able to receive an IV or are unable to swallow a pill. Dsuvia was approved by the European Medicines Agency in June under the name Dzuveo.

Dsuvia was rejected by an FDA advisory committee in 2017 because the committee wanted more data. AcelRx returned to the committee this year, and on October 12 the drug was recommended for approval. It is expected to be available in the first quarter of next year.

"As a single-dose, non-invasive medication with a rapid reduction in pain intensity, DSUVIA represents an important alternative for healthcare providers to offer patients for acute pain management," Dr. David Leiman, clinical assistant of surgery at University of Texas at Houston, said in a statement from AcelRx. Leiman was a researcher on an AcelRx study of Dsuvia in post-surgical patients.

The-CNN-Wire
™ & © 2018 Cable News Network, Inc., a Time Warner Company. All rights reserved.

Terre Haute
Clear
80° wxIcon
Hi: 90° Lo: 67°
Feels Like: 82°
Robinson
Clear
79° wxIcon
Hi: 92° Lo: 66°
Feels Like: 81°
Indianapolis
Few Clouds
78° wxIcon
Hi: 89° Lo: 67°
Feels Like: 80°
Rockville
Clear
76° wxIcon
Hi: 88° Lo: 66°
Feels Like: 76°
Casey
Few Clouds
79° wxIcon
Hi: 90° Lo: 67°
Feels Like: 81°
Brazil
Clear
83° wxIcon
Hi: 89° Lo: 66°
Feels Like: 85°
Marshall
Clear
83° wxIcon
Hi: 90° Lo: 67°
Feels Like: 85°
Sunshine for the afternoon but storms tonight
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Confirmed Cases: 152899

Reported Deaths: 7345
CountyConfirmedDeaths
Cook946054693
Lake10253428
DuPage9571483
Kane8028281
Will7171324
Winnebago3161104
McHenry2229101
St. Clair2202144
Kankakee140165
Unassigned1175201
Rock Island114230
Madison113370
Kendall103223
Champaign101817
Boone63021
Peoria62830
DeKalb61920
Sangamon50933
Jackson34719
McLean30815
Randolph2997
Ogle2864
Stephenson2826
LaSalle24617
Clinton24517
Macon24322
Whiteside20815
Union20219
Coles19017
Grundy1885
Iroquois1725
Tazewell1678
Knox1570
Adams1511
Monroe15013
Warren1470
Williamson1454
Cass1378
Morgan1323
Jefferson11517
Henry1061
Lee1052
McDonough10415
Vermilion862
Pulaski810
Marion770
Montgomery691
Macoupin663
Perry611
Douglas550
Livingston542
Jo Daviess521
Christian494
Jasper477
Woodford442
Ford421
Franklin400
Jersey401
Clark360
Bureau352
Menard310
Cumberland300
Mercer280
Effingham271
Washington250
Johnson240
Mason240
Fayette233
Wabash230
Alexander220
Carroll212
Piatt210
Hancock201
Moultrie200
Shelby201
Bond191
Crawford190
Logan180
Edgar170
De Witt160
Fulton160
Saline160
Wayne161
Massac150
Schuyler130
Marshall120
Brown100
Lawrence90
White90
Greene80
Henderson80
Richland80
Hamilton70
Stark70
Pike60
Gallatin50
Edwards30
Clay20
Hardin20
Out of IL20
Calhoun10
Pope10
Putnam10
Scott10

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Confirmed Cases: 50300

Reported Deaths: 2748
CountyConfirmedDeaths
Marion11920692
Lake5432248
Elkhart347058
Allen2902133
St. Joseph205169
Hamilton1665101
Cass16449
Hendricks1446100
Johnson1325118
Porter80238
Tippecanoe7599
Clark68144
Vanderburgh6816
Madison67264
LaPorte60527
Howard59458
Bartholomew59345
Kosciusko5704
Marshall5308
Noble50128
LaGrange4829
Jackson4783
Boone47444
Delaware46952
Hancock46036
Shelby43525
Floyd40444
Morgan33631
Monroe32928
Grant30926
Dubois2976
Henry29717
Montgomery29720
Clinton2893
White26810
Decatur25532
Dearborn25423
Lawrence25225
Vigo2478
Warrick24329
Harrison21722
Greene19332
Miami1922
Jennings17912
Putnam1728
DeKalb1674
Scott1639
Wayne1536
Daviess15017
Perry1459
Orange13723
Steuben1362
Jasper1332
Franklin1278
Ripley1277
Wabash1152
Carroll1132
Gibson1132
Fayette1057
Whitley1045
Newton10010
Starke983
Huntington932
Randolph794
Wells791
Jefferson782
Fulton731
Jay680
Washington681
Knox670
Clay665
Pulaski661
Rush613
Posey550
Owen521
Benton510
Spencer501
Adams491
Sullivan471
Brown431
Blackford402
Fountain352
Crawford330
Tipton321
Switzerland300
Martin240
Parke230
Ohio220
Vermillion200
Warren151
Union130
Pike110
Unassigned0193